Cortex is creating an innovative, totally integrated, all-encompassing platform for assessing and treating atrial fibrillation.
Cortex has raised $90.0M in total funding. The most recent round was Private Equity. The last funding was announced in December 2023.
Cortex's investors include Hellman & Friedman, Kohlberg Kravis Roberts & Co., AI Life Sciences Investments LLC.
Cortex is headquartered in Menlo Park, United States.
Cortex is creating an innovative, totally integrated, all-encompassing platform for assessing and treating atrial fibrillation.
Cortex is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cortex — Funding & Investors." VCBacked, December 7, 2023, https://www.vcbacked.co/company/cortex. Accessed July 19, 2026.
VCBacked. (2023). Cortex — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/cortex
{{cite web |title=Cortex — Funding & Investors |url=https://www.vcbacked.co/company/cortex |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated